![Albion Fitzgerald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albion Fitzgerald
Nessuna posizione attualmente
Profilo
Albion J.
Fitzgerald was the founder of Novadigm, Inc. founded in 1992, where he held the titles of Chairman, Chief Executive & Technology Officer from 1995 to 2004.
Mr. Fitzgerald is also the founder of Telemetrix, Inc. Mr. Fitzgerald's former jobs include Chairman & Chief Executive Officer at ManageIQ, Inc. from 2007 to 2012, and Independent Director at CohBar, Inc. from 2014 to 2023.
Precedenti posizioni note di Albion Fitzgerald
| Società | Posizione | Fine |
|---|---|---|
| COHBAR | Presidente | 01/04/2021 |
ManageIQ, Inc.
 ManageIQ, Inc. Packaged SoftwareTechnology Services Provides enterprise cloud management and automation solutions | Amministratore Delegato | 01/12/2012 |
Novadigm, Inc.
 Novadigm, Inc. Packaged SoftwareTechnology Services Develops management software products | Amministratore Delegato | 01/01/2004 |
Telemetrix, Inc.
 Telemetrix, Inc. Wireless TelecommunicationsCommunications Provides wireless communications services | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
9
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Novadigm, Inc.
Novadigm, Inc. Packaged SoftwareTechnology Services Develops management software products | Technology Services |
Telemetrix, Inc.
Telemetrix, Inc. Wireless TelecommunicationsCommunications Provides wireless communications services | Communications |
ManageIQ, Inc.
ManageIQ, Inc. Packaged SoftwareTechnology Services Provides enterprise cloud management and automation solutions | Technology Services |
CohBar, Inc.
 CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
